Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Unique Challenges and Advances in Mucosal Dermatology: Focus on Lichen Planus
Description
Dr. Aaron Foster, a leading expert in mucosal dermatology, discusses the complexities of diagnosing and treating mucosal diseases, particularly focusing on lichen planus. She highlights the challenges faced in understanding the inflammatory pathways involved, noting that current research primarily consists of descriptive studies with limited appropriate models. By using oral lichen planus as a model, she illustrates how different presentations—such as erosive versus reticular—can complicate diagnosis and treatment. Recent advances include identifying saliva biomarkers and differentially expressed genes that may aid in early diagnosis. Despite these technological advancements, literature often lacks standardized definitions and treatment guidelines, which stymie progress in research and therapeutic practices. Dr. Foster advocates for a nuanced approach to treatment, emphasizing the importance of understanding the specific subtype of lichen planus to guide effective therapy. Current treatment strategies vary from topical corticosteroids for less severe forms to systemic biologics for treatment-resistant cases. She concludes by emphasizing the need for more comprehensive research, standardized outcome measures, and ultimately, a more personalized approach to treating mucosal diseases.
View moreConclusions
- Mucosal diseases like lichen planus exhibit diverse clinical presentations requiring tailored diagnostic approaches.
- Current research focuses on understanding the inflammatory pathways in mucosal diseases, but clarity in pathology remains limited.
- Identification of differentially expressed saliva markers can facilitate early diagnosis of conditions like erosive oral lichen planus.
- Differential expression of cytokines in saliva may be useful in monitoring treatment responses in mucosal diseases.
- Recent studies indicate that various T cell populations contribute to the pathogenesis of mucosal lichen planus, necessitating more differentiated therapeutic strategies.
- Systemic treatments for erosive oral lichen planus are being explored as they may offer better outcomes than traditional topical treatments.
- The one-size-fits-all approach in treating mucosal diseases is inadequate, emphasizing the need for subtype-specific therapeutic interventions.
- Collaborative research across specialties is critical to advance the understanding and treatment of mucosal diseases.
- Rees T, Desquamative Gingivitis CE, 2019
- Gudjonsson JE, Clin Exp Immunol, 2004
- Mohd Noor, Biomechanisms, 2023
- El-Howati A, Oral Diseases, 2022
- Muller S, Mod Pathol, 2017
- Klein BA, Front Oral Health, 2022
- McParland H, J Biomed Biotech, 2012
- Jiang L, Heliyon, 2024
- Vo, PLoS One, 2021
- Didona, Front Med, 2022
- Abduelmula A, J Cut Med Surg, 2023
- Del Toro, JAAD, Nov 2024
- Marlene Wijaya, Gayle Fischer & Rebecca Bronwyn Saunderson, Trials 25, Article number: 181 (2024) | Cite this article
- Xin M, Front Oncol, 2021
- Yao, BMC Oral Health, 2024